Cardiovascular Dynamics, Exercise Physiology, and Nutritional Ergogenics

Muscle Glycogen Utilization and Exercise Metabolism

• Intensity-Dependent Glycogen Depletion:
  • Muscle glycogen utilization is directly proportional to exercise intensity. As workload increases, the rate of glycogenolysis in active skeletal muscle accelerates exponentially.
  • When exercising to exhaustion at supramaximal intensities, time to exhaustion is dictated by the depletion of intramuscular glycogen stores:
  • Exercise at $120\%\,\dot{V}\text{O}_2\text{max}$ results in exhaustion in approximately $20\,\text{min}$.
  • Exercise at $150\%\,\dot{V}\text{O}_2\text{max}$ accelerates glycogen depletion, causing exhaustion in approximately $8.5\,\text{min}$.

• Dietary Carbohydrate Impact on Glycogen Stores and Performance:
  • Consuming a high-carbohydrate diet ($\sim 600\,\text{g}\cdot\text{d}^{-1}$) for $3\,\text{d}$ elevates skeletal muscle glycogen content to $35.2\,\text{g}\cdot\text{kg}^{-1}\,\text{muscle}$, compared to $17.7\,\text{g}\cdot\text{kg}^{-1}\,\text{muscle}$ following a standard "mixed" diet.

• During a $30\,\text{km}$ ($19\,\text{miles}$) running time trial:
  • Athletes consuming a high-carbohydrate diet complete the distance in an average of $135.3\,\text{min}$.
  • Athletes consuming a mixed diet complete the distance in an average of $143.0\,\text{min}$.
  • Running pace begins to drop precipitously at the exact point where muscle glycogen content is depleted. Elevated pre-exercise glycogen stores allow athletes to maintain high exercise intensity and running pace throughout the duration of prolonged competition.

Glycogen Supercompensation Strategies

• Supercompensation Definition:

  • The increase in skeletal muscle glycogen concentration significantly above normal resting baseline concentrations ($100\text{--}120\,\text{mmol}\cdot\text{kg}^{-1}\,\text{wet weight}$ or $\sim 15\text{--}18\,\text{g}\cdot\text{kg}^{-1}$).

• Enzymatic Regulation of Glycogenesis:

  • Glycogen synthase is the rate-limiting enzyme catalyzing glycogenesis (converting glucose into stored glycogen).
  • Exercise ($40\,\text{min}$ at $70\,\%\,\dot{V}\text{O}_2\text{max}$) depletes intramuscular glycogen from $\sim 500\,\text{mmol}\cdot\text{kg}^{-1}\,\text{dry weight}$ to $\sim 240\,\text{mmol}\cdot\text{kg}^{-1}\,\text{dry weight}$, which simultaneously stimulates an increase in glycogen synthase fractional activity ($\text{FV}_{1.67}$) from $\sim 46\,\%$ up to $\sim 71\,\%$.
  • Glycogen synthase activity remains elevated ($\sim 79\,\%$) for at least $3.5\,\text{h}$ post-exercise, creating an optimal intracellular environment for rapid resynthesis.

• The "Classic" Supercompensation Protocol:

  • Day 1: Perform prolonged, high-intensity, glycogen-depleting exercise.
  • Days 2–4: Consume a low-carbohydrate, high-fat/protein diet for $3\,\text{d}$ while maintaining training sessions to exhaust remaining glycogen pools.
  • Days 5–7: Consume a high-carbohydrate diet ($90\,\%$ of total daily calories) for $3\,\text{d}$ while remaining inactive (tapered to complete rest) to achieve supercompensation.
  • Practical Limitations of the Classic Method:
  • Requires a full $7\,\text{d}$ cycle prior to competition.
  • Low-carbohydrate diets are difficult to tolerate during intense training, leading to lethargy, hypoglycemia, irritability, and elevated injury risk.
  • Consuming $90\,\%$ of energy as carbohydrates on a $4000\,\text{kcal}\cdot\text{d}^{-1}$ diet requires $\sim 860\,\text{g}\cdot\text{d}^{-1}$ of carbohydrates, causing significant gastrointestinal distress.

• The "Modified" Supercompensation Protocol:

  • Days 1–3: Taper exercise duration from $90\,\text{min}$ down to $40\,\text{min}$ at $70\text{--}75\,\%\,\dot{V}\text{O}_2\text{max}$ while consuming a standard mixed diet containing $50\,\%$ carbohydrate ($350\,\text{g}\cdot\text{d}^{-1}$).
  • Days 4–5: Reduce exercise training to $20\,\text{min}$ per day while increasing dietary carbohydrate intake to $70\,\%$ of total daily energy ($550\,\text{g}\cdot\text{d}^{-1}$).
  • Day 6: Complete rest day prior to competition while maintaining the $70\,\%$ carbohydrate diet ($550\,\text{g}\cdot\text{d}^{-1}$).
  • Day 7: Competition day with maximized glycogen stores, achieved without an exhaustive initial depletion phase or severe dietary restrictions.

• Single-Day High-Carbohydrate Protocol:
  • In well-trained endurance athletes, supercompensation can be attained within $24\,\text{h}$.
  • Ingesting $10\,\text{g}$ of carbohydrates per kilogram of body weight ($\sim 770\,\text{g}\cdot\text{d}^{-1}$) combined with physical inactivity increases muscle glycogen content from $\sim 95\,\text{mmol}\cdot\text{kg}^{-1}\,\text{wet weight}$ to $\sim 180\,\text{mmol}\cdot\text{kg}^{-1}\,\text{wet weight}$ within $24\,\text{h}$.
  • Extending this high-carbohydrate regimen to $72\,\text{h}$ yields no further statistically significant increase ($\sim 193\,\text{mmol}\cdot\text{kg}^{-1}\,\text{wet weight}$).

• Glycogen Normalization:
  • Day-to-day glycogen restoration in athletes undergoing daily training requires $550\text{--}600\,\text{g}\cdot\text{d}^{-1}$ of carbohydrates ($7\text{--}10\,\text{g}\cdot\text{kg}^{-1}\cdot\text{d}^{-1}$), which is routinely achieved through standard nutritional planning without formal loading protocols.

Post-Exercise Carbohydrate Nutrition and Insulin Kinetics

• Glycemic Index (GI):
  • Glycemic index measures the extent to which a specific carbohydrate food elevates blood glucose concentrations compared to an equivalent mass of a standard reference food (pure glucose or white bread, defined as $100$).
  • High-GI foods (such as white rice, baked potatoes, maltodextrin) induce rapid spikes in plasma glucose and insulin, making them superior for post-exercise recovery.
  • Low-GI foods (such as beans, lentils, whole-grain oats, pasta) yield gradual glucose elevations and are preferred for sustained energy release outside of acute recovery periods.

• Endocrine Actions of Insulin:
  • Elevated blood glucose post-ingestion stimulates pancreatic $\beta$-cells to secrete insulin.
  • Plasma insulin concentrations decline progressively during acute exercise as intensity increases, driven by sympathetic inhibition.
  • Systemic target actions of insulin include:
  • Skeletal muscle and most tissues: Promotes GLUT4 translocation to the sarcolemma, stimulating cellular glucose uptake; increases amino acid uptake and protein synthesis while inhibiting proteolysis.
  • Adipose tissue: Stimulates fatty acid and triacylglycerol synthesis; suppresses lipolysis by inhibiting hormone-sensitive lipase.
  • Liver: Promotes glycogen synthesis; suppresses gluconeogenesis and glycogenolysis.

• Timing of Post-Exercise Carbohydrate Ingestion:
  • Carbohydrate ingestion immediately post-exercise ($2\,\text{g}\cdot\text{kg}^{-1}$) promotes significantly faster glycogen resynthesis rates ($0\text{--}2\,\text{h}$) than delaying ingestion by $2\,\text{h}$.
  • Even though delayed feeding produces a similar absolute insulin surge once carbohydrates are consumed, the cumulative $4\,\text{h}$ glycogen storage is cut in half.
  • Mechanisms of enhanced immediate storage:
  • Elevated muscle membrane GLUT4 content persists following muscle contraction.
  • Whole-body glucose disposal rate ($\text{R}_d$) and insulin sensitivity remain elevated for up to $90\text{--}120\,\text{min}$ post-exercise before returning to baseline.
  • Practical guideline: Ingest carbohydrates within $30\,\text{min}$ of completing exhaustive exercise, targeting $\sim 1.0\text{--}1.2\,\text{g}\cdot\text{kg}^{-1}\cdot\text{h}^{-1}$.

Protein Ingestion and Exercise Interactions

• Amino Acid Utilization During Endurance Exercise:

  • Prolonged exercise elevates cortisol, activating skeletal muscle proteolysis.
  • Released branched-chain amino acids (notably leucine) are transaminated to pyruvate to yield alanine, which enters the circulation and travels to the liver for gluconeogenesis (glucose-alanine cycle).
  • Leucine oxidation rates increase significantly during $90\,\text{min}$ of moderate exercise ($60\,\%\,\dot{V}\text{O}_2\text{max}$) over basal resting values:
  • Women exhibit a $90.2\,\%$ increase in leucine oxidation.
  • Men exhibit a $94.1\,\%$ increase in leucine oxidation.

• Carbohydrate-Protein Co-Ingestion After Endurance Exercise:

  • Co-ingesting $112\,\text{g}$ carbohydrate and $41\,\text{g}$ protein immediately and $2\,\text{h}$ post-exercise yields significantly greater plasma insulin responses than carbohydrate alone, driving faster rates of muscle glycogen resynthesis ($35.5\,\mu\text{mol}\cdot\text{g}^{-1}\cdot\text{h}^{-1}$ vs. $25.6\,\mu\text{mol}\cdot\text{g}^{-1}\cdot\text{h}^{-1}$).
  • Protein co-ingestion stimulates fractional synthetic rate (FSR) of mixed muscle protein, mitigating post-exercise negative nitrogen balance.

• Carbohydrate-Protein Ingestion After Resistance Exercise:
  • Post-resistance exercise muscle protein synthesis is driven primarily by essential amino acid availability.
  • Ingesting $21\,\text{g}$ protein alone, $21\,\text{g}$ protein with low carbohydrate ($11\,\text{g}$), or $21\,\text{g}$ protein with high carbohydrate ($43\,\text{g}$) yields identical mixed-muscle FSR ($\sim 0.10\text{--}0.11\,\%\cdot\text{h}^{-1}$), despite a dramatic graded rise in $6\,\text{h}$ cumulative insulin exposure ($1.6$ vs. $3.8$ vs. $18.4\,\text{U}\cdot 6\,\text{h}\cdot\text{L}^{-1}$).
  • Although carbohydrate does not further augment resistance-exercise-induced muscle protein synthesis when sufficient protein ($\ge 20\text{--}25\,\text{g}$) is provided, post-resistance carbohydrate intake remains necessary to restore depleted glycogen stores ($8$ sets of $10$ repetitions of leg extensions at $75\,\%$ of $1\text{RM}$ depletes glycogen by $24.3\text{--}45.6\,\%$).

Creatine Supplementation Physiology

• Intramuscular Phosphocreatine (PCr) Kinetics:

  • Baseline total muscle creatine (TCr) averages $\sim 120\text{--}125\,\text{mmol}\cdot\text{kg}^{-1}\,\text{dry weight}$.
  • Classic loading regimen: Ingesting $20\,\text{g}\cdot\text{d}^{-1}$ of creatine monohydrate for $5\text{--}6\,\text{d}$ elevates intramuscular PCr and TCr stores by $\sim 20\,\%$.
  • Maintenance: Ingesting a daily maintenance dose of $2\,\text{g}\cdot\text{d}^{-1}$ sustains elevated muscle creatine concentrations for at least $28\,\text{d}$, whereas complete cessation results in a slow decline toward pre-supplementation baseline levels within $4\text{--}5\,\text{weeks}$.

• Performance Adaptations:

  • Upper body dynamic strength: In trained women completing a $5\,\text{wk}$ resistance training program, creatine supplementation ($5\,\text{g}\cdot\text{d}^{-1}$ for $1\,\text{wk}$, then $2\,\text{g}\cdot\text{d}^{-1}$ for $4\,\text{wk}$) increased bench press $1\text{RM}$ by $6.2\,\text{kg}$ ($+16.7\,\%$), compared to $2.8\,\text{kg}$ ($+7.1\,\%$) in placebo controls.
  • Muscular endurance: In men undergoing $12\,\text{wk}$ of training, creatine supplementation ($27\,\text{g}\cdot\text{d}^{-1}$ for $5\,\text{d}$, then $6\,\text{g}\cdot\text{d}^{-1}$) increased repetitions performed at $80\,\%$ of $1\text{RM}$ by $+28\,\%$ at $6\,\text{weeks}$ and $+26\,\%$ at $12\,\text{weeks}$ relative to controls.
  • Sprint performance and "Non-Responders":
  • Creatine supplementation enhances peak power output during repeated high-intensity sprint cycling intervals ($5 \times 10\,\text{s}$ sprints).
  • Individuals with inherently high initial baseline total creatine stores ($>140\,\text{mmol}\cdot\text{kg}^{-1}\,\text{dry weight}$) exhibit negligible uptake and performance enhancement ("non-responders").

• Carbohydrate-Mediated Creatine Retention:

  • Ingesting $5\,\text{g}$ creatine combined with $93\,\text{g}$ simple carbohydrates markedly enhances muscle creatine accumulation:
  • Increases total creatine by $33\,\text{mmol}\cdot\text{kg}^{-1}\,\text{dry muscle}$ compared to $20\,\text{mmol}\cdot\text{kg}^{-1}$ with creatine alone.
  • Stimulates a robust insulin surge ($148.7\,\text{mIU}\cdot\text{L}^{-1}$ at $20\,\text{min}$ vs. $7.3\,\text{mIU}\cdot\text{L}^{-1}$ in creatine alone).
  • Reduces Day 1 urinary creatine excretion from $9.5\,\text{g}$ down to $5.2\,\text{g}$, demonstrating greater whole-body retention driven by insulin-mediated sodium-dependent creatine transporter (CreaT) activity and enhanced skeletal muscle blood flow.

Systemic Organization and Principles of Oxygen Consumption

• Cardiovascular Architecture:
  • Pulmonary Circuit: Systemic venous return enters the right atrium via the superior and inferior vena cava $\rightarrow$ tricuspid valve $\rightarrow$ right ventricle $\rightarrow$ pulmonary valve $\rightarrow$ pulmonary trunk and arteries $\rightarrow$ pulmonary capillary bed (gas exchange: $\text{O}_2$ loading, $\text{CO}_2$ unloading) $\rightarrow$ pulmonary veins $\rightarrow$ left atrium.
  • Systemic Circuit: Oxygenated blood passes through the bicuspid (mitral) valve $\rightarrow$ left ventricle $\rightarrow$ aortic semilunar valve $\rightarrow$ aorta and large conduits $\rightarrow$ muscular resistance arterioles $\rightarrow$ systemic tissue capillaries (metabolite and gas delivery) $\rightarrow$ post-capillary venules $\rightarrow$ systemic veins $\rightarrow$ vena cava.

• Fick Equations for Oxygen Consumption:

  • Pulmonary Gas Exchange Equation:     $\dot{V}\text{O}_2 = \dot{V}_E \times (F_I\text{O}_2 - F_E\text{O}_2)$
  • $\dot{V}\text{O}_2$: Oxygen consumption rate ($\text{L}\cdot\text{min}^{-1}$).
  • $\dot{V}_E$: Minute ventilation ($\text{L}\cdot\text{min}^{-1}$).
  • $F_I\text{O}_2$: Fractional oxygen content of ambient inspired air (constant at $0.2093$ or $20.93\,\%$).
  • $F_E\text{O}_2$: Fractional oxygen content of expired air.
  • Worked example: If $\dot{V}_E = 69.0\,\text{L}\cdot\text{min}^{-1}$, $F_I\text{O}_2 = 0.2082$, and $F_E\text{O}_2 = 0.1682$:       $\dot{V}\text{O}_2 = (69.0\,\text{L}\cdot\text{min}^{-1}) \times (0.2082 - 0.1682) = 69.0 \times 0.04 = 2.76\,\text{L}\cdot\text{min}^{-1}$
  • Circulatory Fick Principle:     $\dot{V}\text{O}_2 = \dot{Q} \times (a - \bar{v})\text{O}_2$
  • $\dot{Q}$: Cardiac output ($\text{L}\cdot\text{min}^{-1}$), representing total systemic blood flow.
  • $(a - \bar{v})\text{O}_2$: Arteriovenous oxygen difference ($\text{mL O}_2\cdot\text{L}^{-1}\,\text{blood}$ or $\text{mL O}_2\cdot 100\,\text{mL}^{-1}$), representing systemic tissue oxygen extraction.

• Oxygen Distribution at Exercise:

  • During submaximal exercise at $77\,\%\,\dot{V}\text{O}_2\text{max}$, whole-body pulmonary $\dot{V}\text{O}_2$ is $1.35\,\text{L}\cdot\text{min}^{-1}$, while active skeletal muscle $\dot{V}\text{O}_2$ is $1.00\,\text{L}\cdot\text{min}^{-1}$.
  • Contracting skeletal muscle accounts for $\sim 74\,\%$ of total systemic oxygen consumption, with the remainder consumed by myocardial tissue, respiratory musculature, and essential splanchnic/renal vascular beds.

Peripheral Hemodynamics and Microvascular Gas Exchange

• Kinetics of $\dot{V}\text{O}_2$, Arterial-Venous Extraction, and Blood Flow:
  • During intense single-leg knee extensor exercise ($120\,\%\,\dot{V}\text{O}_2\text{max}$, $3\,\text{min}$ duration):
  • Thigh $\dot{V}\text{O}_2$ increases from a baseline of $32\,\text{mL}\cdot\text{min}^{-1}$ to $102\,\text{mL}\cdot\text{min}^{-1}$ by $6\,\text{s}$ ($+219\,\%$), reaching $789\,\text{mL}\cdot\text{min}^{-1}$ at $180\,\text{s}$.
  • Arteriovenous oxygen difference ($(a - \bar{v})\text{O}_2$) expands from $18\,\text{mL}\cdot\text{L}^{-1}$ at rest to $43\,\text{mL}\cdot\text{L}^{-1}$ by $6\,\text{s}$ ($+139\,\%$) and $146\,\text{mL}\cdot\text{L}^{-1}$ by $180\,\text{s}$ ($+711\,\%$).
  • Arterial oxygen content ($a$) rises slightly from $189\,\text{mL}\cdot\text{L}^{-1}$ to $201\,\text{mL}\cdot\text{L}^{-1}$ within $15\,\text{s}$ due to hemoconcentration, then remains tightly regulated.
  • Venous oxygen content ($\bar{v}$) drops rapidly from $172\,\text{mL}\cdot\text{L}^{-1}$ down to $55\,\text{mL}\cdot\text{L}^{-1}$ at $180\,\text{s}$, indicating extensive peripheral extraction.
  • Example at $30\,\text{s}$: $a = 200\,\text{mL}\cdot\text{L}^{-1}$, $\bar{v} = 80\,\text{mL}\cdot\text{L}^{-1} \implies (a - \bar{v}) = 120\,\text{mL}\cdot\text{L}^{-1}$ extracted by active muscle.

• Capillary Diffusive Transport Mechanisms:
  • Capillaries serve as the primary exchange vessels for nutrients ($\text{glucose}$, $\text{fatty acids}$) and respiratory gases ($\text{O}_2$, $\text{CO}_2$).

• Increasing exercise intensity widens the arteriovenous glucose gradient ($(a - \bar{v})\,\text{glucose}$), reflecting elevated metabolic uptake.
• Intracellular lactate production drives active transport into venous blood via monocarboxylate transporters (MCTs), causing venous lactate to rise substantially above arterial concentrations during intense work ($110\,\%\,\dot{V}\text{O}_2\text{max}$).

• Intramyocellular and Microvascular Oxygen Tensions:

  • Resting conditions ($6\,\%\,\dot{V}\text{O}_2\text{max}$):
  • Capillary $P\text{O}_2 = 38\,\text{mm\,Hg}$.
  • Intracellular myocyte $P\text{O}_2 = 34\,\text{mm\,Hg}$.
  • Net pressure gradient driving diffusion across the sarcolemma is only $4\,\text{mm\,Hg}$.
  • Submaximal and Maximal Exercise ($50\text{--}100\,\%\,\dot{V}\text{O}_2\text{max}$):
  • Capillary $P\text{O}_2$ remains stable between $39\text{--}40\,\text{mm\,Hg}$.
  • Intracellular $P\text{O}_2$ collapses immediately to $\sim 3.4\text{--}3.0\,\text{mm\,Hg}$ due to rapid mitochondrial consumption.
  • The resulting trans-sarcolemmal diffusive gradient expands to $36\text{--}37\,\text{mm\,Hg}$, driving rapid oxygen flux.
  • Intracellular $P\text{O}_2$ remains invariant at $\sim 3\text{--}3.4\,\text{mm\,Hg}$ across light, moderate, and maximal exercise; increases in total muscle oxygen uptake are therefore mediated by increases in convective microvascular oxygen delivery (blood flow) and functional capillary recruitment.

• Oxygen Delivery and Vascular Conductance:

  • Convective oxygen delivery is the mathematical product of regional blood flow and arterial oxygen content:     $\text{O}_2\,\text{Delivery} (\text{mL}\cdot\text{min}^{-1}) = \text{Blood Flow} (\text{L}\cdot\text{min}^{-1}) \times \text{Arterial O}_2\,\text{Content} (\text{mL}\cdot\text{L}^{-1})$
  • Leg blood flow during intense knee-extensor exercise increases from $1.71\,\text{L}\cdot\text{min}^{-1}$ at baseline to $2.59\,\text{L}\cdot\text{min}^{-1}$ by $7\,\text{s}$ ($+52\,\%$) and $5.39\,\text{L}\cdot\text{min}^{-1}$ by $180\,\text{s}$ ($+215\,\%$).
  • Exercise intensity comparisons at $120\,\text{s}$:
  • Submaximal ($30\,\%\,\dot{V}\text{O}_2\text{max}$): Blood flow = $2.7\,\text{L}\cdot\text{min}^{-1}$, $(a - \bar{v})\text{O}_2 = 131\,\text{mL}\cdot\text{L}^{-1}$.
  • Supramaximal ($120\,\%\,\dot{V}\text{O}_2\text{max}$): Blood flow = $5.3\,\text{L}\cdot\text{min}^{-1}$ ($+96\,\%$), $(a - \bar{v})\text{O}_2 = 144\,\text{mL}\cdot\text{L}^{-1}$ ($+10\,\%$).
  • The vast majority of the increase in muscle $\dot{V}\text{O}_2$ from moderate to supramaximal exercise is driven by convective blood flow rather than widened extraction.

• Experimental Suppression of Blood Flow:

  • Intra-arterial infusion of $N^G\text{-monomethyl-L-arginine}$ (L-NMMA, nitric oxide synthase inhibitor) plus indomethacin (cyclooxygenase/prostanoid inhibitor) selectively blunts local hyperemia, causing a $30\text{--}50\,\%$ reduction in leg blood flow during submaximal exercise ($30\,\%\,\dot{V}\text{O}_2\text{max}$).
  • Muscle compensation: The active tissue compensates by increasing fractional oxygen extraction, lowering femoral venous oxygen content from $75\,\text{mL}\cdot\text{L}^{-1}$ down to $40\,\text{mL}\cdot\text{L}^{-1}$ and increasing leg $(a - \bar{v})\text{O}_2$ from $130\,\text{mL}\cdot\text{L}^{-1}$ to $160\,\text{mL}\cdot\text{L}^{-1}$.
  • As a result of widened extraction, steady-state active quadriceps $\dot{V}\text{O}_2$ is preserved despite reduced vascular perfusion.

Cardiac Anatomy, Cellular Architecture, and Myocardial Metabolism

• Cardiac Morphology and Functional Topology:
  • Right atrium receives deoxygenated blood from the superior vena cava, inferior vena cava, and coronary sinus.
  • Tricuspid atrioventricular valve connects the right atrium to the right ventricle; ventricular papillary muscles attach to the valve leaflets via chordae tendineae to prevent eversion during systole.
  • Right ventricle ejects deoxygenated blood through the pulmonary valve into the pulmonary arterial system.
  • Left atrium receives oxygenated pulmonary venous blood and transmits it across the bicuspid (mitral) valve to the left ventricle.
  • Left ventricle possesses a thick muscular wall to pump blood across the aortic valve into the systemic arterial tree.

• Coronary Vasculature:
  • The coronary arteries arise from ostia situated at the base of the aorta immediately distal to the aortic valve leaflets.
  • Left main coronary artery bifurcates into the circumflex artery (supplying the lateral/posterior left ventricle) and left anterior descending (LAD) artery (supplying the anterior wall and interventricular septum).
  • Right coronary artery courses along the coronary sulcus, branching into the marginal artery and posterior interventricular artery.
  • Coronary capillary blood drains into cardiac veins that converge at the coronary sinus, returning venous blood directly into the right atrium.

• Histological and Biochemical Characteristics of Cardiomyocytes:
  • Cardiomyocytes are short, branched, predominantly mono-nucleated cells containing central nuclei and cross-striations formed by sarcomeric contractile proteins.
  • Contain the $\beta$-cardiac myosin heavy chain (MHC) isoform, which is functionally and structurally homologous to the MHC 1 isoform of skeletal muscle Type 1 Slow Oxidative (SO) fibers.

• Contractile and metabolic properties of MHC 1 / $\beta$-cardiac muscle vs. Type 2X fibers:
  • Myosin ATPase activity: Low (MHC 1) vs. High (MHC 2X).
  • Isometric twitch tension: Low (MHC 1) vs. High (MHC 2X).
  • Mitochondrial volume density: High (MHC 1) vs. Low (MHC 2X).
  • Fatigue resistance: High (MHC 1) vs. Low (MHC 2X).
• Intercalated Discs:
  • Intercellular junctions that mechanically and electrically link adjacent myocytes.
  • Desmosomes: Composed of cadherin linkers and intermediate keratin filaments anchored to dense plaques, providing high mechanical tensile strength to prevent cellular separation during forceful contraction.
  • Gap Junctions: Composed of hexameric connexon channels traversing the intercellular space, allowing low-resistance passage of ions to facilitate synchronized electrical syncytium transmission.

• Myocardial Substrate Preference During Graded Exercise:
  • Resting state: Fatty acids serve as the primary oxidative substrate, accounting for $\sim 65\,\%$ of ATP production, with glucose and glycogen supplying $\sim 30\,\%$ and lactate $\sim 5\,\%$.
  • Moderate exercise: Fuel utilization becomes mixed; glucose and glycogen contribute $\sim 38\,\%$, fatty acids $\sim 32\,\%$, and circulating lactate increases to $\sim 30\,\%$.
  • Intense exercise: Circulating lactate becomes the dominant oxidative fuel source for the heart ($\sim 70\,\%$ of total myocardial substrate consumption), while fatty acids decline to $\sim 20\,\%$ and glucose/glycogen falls to $\sim 10\,\%$.

Cardiac Electrophysiology, Conduction, and Electrocardiography

• Cardiac Conduction Network Sequence:
  1. Sinoatrial (SA) Node: Located in the superior anterolateral wall of the right atrium near the entrance of the superior vena cava. Spontaneously generates action potentials acting as the primary cardiac pacemaker.
  2. Atrial Syncytium: Wave of depolarization spreads across gap junctions throughout the right and left atria, triggering atrial contraction.
  3. Atrioventricular (AV) Node: Located in the inferior interatrial septum. Depolarization passes to the AV node, where conduction velocity slows significantly ($\sim 0.1\,\text{s}$ delay), permitting complete ventricular filling before ventricular systole.
  4. Atrioventricular (AV) Bundle (Bundle of His): Conveys the impulse from the atria into the ventricles through the non-conductive fibroelastic cardiac skeleton.
  5. Left and Right Bundle Branches: Travel inferiorly down both sides of the interventricular septum toward the apex of the heart.
  6. Purkinje Fibers: Large-diameter, fast-conducting specialized fibers distribute depolarization superiorly throughout the ventricular myocyte syncytium, initiating contraction from the cardiac apex upward toward the outflow tracts.

• Sinoatrial Pacemaker Action Potentials:
  • Unlike neurons and skeletal muscle fibers, SA nodal pacemaker cells possess no stable resting membrane potential.
  • Pacemaker Potential (Diastolic Depolarization): Slow spontaneous drift from an initial maximum diastolic potential of $-60\,\text{mV}$ up to the threshold potential of $-40\,\text{mV}$. This is initiated by hyperpolarization-activated cyclic nucleotide-gated channels carrying an inward $\text{Na}^+$ flux, followed by inward transient (T-type) $\text{Ca}^{2+}$ current.
  • Depolarization Phase: Reaching $-40\,\text{mV}$ triggers voltage-gated L-type $\text{Ca}^{2+}$ channels; the rapid influx of $\text{Ca}^{2+}$ causes the action potential upstroke to $\sim 0\text{--}+10\,\text{mV}$.
  • Repolarization Phase: Inactivation of $\text{Ca}^{2+}$ channels and delayed opening of voltage-gated $\text{K}^+$ channels promotes $\text{K}^+$ efflux, repolarizing the cell membrane back to $-60\,\text{mV}$.
  • Intrinsic SA node pacing rate without autonomic input is $\sim 100\,\text{beats}\cdot\text{min}^{-1}$.

• Ventricular Myocyte Action Potentials and Excitation-Contraction Coupling:
  • Phase 4 (Resting State): Membrane potential maintained stable at $-90\,\text{mV}$ by inward rectifier $\text{K}^+$ channels.
  • Phase 0 (Rapid Depolarization): Rapid opening of voltage-gated fast $\text{Na}^+$ channels causes explosive $\text{Na}^+$ influx, driving the membrane to $\sim +30\,\text{mV}$.
  • Phase 1 (Early Transient Repolarization): Fast $\text{Na}^+$ channels inactivate while transient outward $\text{K}^+$ channels open, producing a brief notch.
  • Phase 2 (Plateau Phase): A prolonged depolarized plateau lasting $\sim 200\text{--}300\,\text{ms}$ sustained by an equilibrium between inward $\text{Ca}^{2+}$ movement through L-type dihydropyridine (DHP) channels and outward $\text{K}^+$ current through delayed rectifiers. This prolonged refractory period prevents tetanic summation in cardiac tissue.
  • Phase 3 (Final Repolarization): Closure of L-type $\text{Ca}^{2+}$ channels and vigorous $\text{K}^+$ efflux via delayed rectifier channels returns the membrane to $-90\,\text{mV}$.
  • Calcium-Induced Calcium Release (CICR): Trans-sarcolemmal $\text{Ca}^{2+}$ influx during Phase 2 binds to and opens ryanodine receptor type 2 (RyR2) channels on the terminal cisternae of the sarcoplasmic reticulum (SR), flooding the cytosol with stored $\text{Ca}^{2+}$.
  • Intracellular $\text{Ca}^{2+}$ binds to troponin C, moving the troponin-tropomyosin complex off actin active sites to allow cross-bridge cycling and force generation.
  • Relaxation: Cytosolic $\text{Ca}^{2+}$ is pumped back into the SR by the sarco/endoplasmic reticulum $\text{Ca}^{2+}$-ATPase 2 (SERCA2) pump and exported extracellularly by the $3\,\text{Na}^+/\text{Ca}^{2+}$ antiporter (NCX) and plasma membrane $\text{Ca}^{2+}$-ATPase.

• Electrocardiographic (ECG) Deflections and Pathologies:
  • P wave: Represents atrial depolarization; triggers subsequent atrial mechanical systole.
  • QRS complex: Represents rapid ventricular depolarization; obscures atrial repolarization; triggers ventricular systole.
  • T wave: Represents ventricular repolarization, preceding ventricular mechanical diastole.
  • PR interval: Measures conduction time from the SA node through the AV node ($0.12\text{--}0.20\,\text{s}$).
  • ST segment: Isoelectric period during which ventricles remain completely depolarized (corresponds to the Phase 2 action potential plateau).
  • QT interval: Duration of total ventricular electrical activity (depolarization and repolarization).

• AV Conduction Blocks:
  • Pathology where electrical propagation through the AV node or bundle branches is impaired.
  • Second- and third-degree AV blocks show non-conducted P waves that fail to elicit a QRS complex, compromising ventricular rate and cardiac output.

• Exercise-Induced Ischemia:
  • Myocardial ischemia (hypoperfusion via atherosclerotic coronary narrowing) is clinically diagnosed by significant depression of the ST-segment ($\ge 1\,\text{mm}$ below the isoelectric line) during graded exercise testing.

Neural Control of Heart Rate and Hemodynamics

• Autonomic Organization:
  • The autonomic nervous system provides extrinsic regulation of cardiac function through parasympathetic and sympathetic divisions.

• Parasympathetic Control:
  • Vagal efferents release acetylcholine (ACh) onto $\text{M}_2$ muscarinic receptors on the SA node.
  • ACh activates inward-rectifying potassium channels ($\text{K}_{\text{ACh}}$), accelerating $\text{K}^+$ efflux and hyperpolarizing the maximum diastolic potential while slowing the slope of the pacemaker potential.
  • Result: Lengthens the time required to reach threshold ($-40\,\text{mV}$), decreasing action potential frequency and heart rate.

• Sympathetic Control:

  • Sympathetic postganglionic terminals release norepinephrine (NE), and the adrenal medulla releases epinephrine (E), which bind myocardial $\beta_1$-adrenergic receptors.

  • Activates cyclic AMP (cAMP) and protein kinase A (PKA), increasing inward $\text{Na}^+$ ("funny") and $\text{Ca}^{2+}$ channel conductance.

  • Result: Increases the slope of the pacemaker potential, shortening the time to threshold and accelerating action potential firing rate.

  • Heart Rate Transitions from Rest to Exercise:

• Resting heart rate ($60\text{--}80\,\text{bpm}$) is maintained below the intrinsic SA pacing rate ($100\,\text{bpm}$) by tonic parasympathetic vagal stimulation ("vagal tone").

• Increasing heart rate from rest up to $100\,\text{bpm}$ during light-to-moderate exercise is driven primarily by the withdrawal of parasympathetic vagal outflow.

• Increasing heart rate above $100\,\text{bpm}$ requires active sympathetic stimulation via norepinephrine and circulating epinephrine, coupled with complete vagal suppression.

• Heart rate increases linearly with graded exercise intensity up to maximal heart rate:     $\text{HR}_{\text{max}} = 207 - (0.7 \times \text{age in years})$

Cardiac Cycle Mechanics and Stroke Volume Regulation

• Mechanical Phases of the Cardiac Cycle:

  • Diastole (Ventricular Filling):
  • Pressure in relaxed ventricles drops below atrial pressure; atrioventricular (AV) valves open.
  • Passive filling occurs first, followed by the ECG P wave, which triggers atrial contraction to top off ventricular volume.
  • End-Diastolic Volume (EDV): Volume of blood contained in the left ventricle at the conclusion of diastole ($\sim 110\text{--}130\,\text{mL}$ at rest; expands to $150\text{--}205\,\text{mL}$ during exercise).
  • Systole (Ventricular Ejection):
  • Ventricular excitation (ECG QRS complex) triggers isovolumetric contraction; intraventricular pressure exceeds atrial pressure, snapping AV valves shut (first heart sound, S1).
  • When left ventricular pressure exceeds systemic aortic pressure ($>80\,\text{mm\,Hg}$ at rest), the aortic semilunar valve opens, ejecting blood into the aorta.
  • End-Systolic Volume (ESV): Residual blood volume remaining in the left ventricle at the end of ejection ($\sim 40\text{--}50\,\text{mL}$ at rest; declines to $30\,\text{mL}$ during exercise).

• Stroke Volume Calculations:

  • Stroke volume (SV) is the volume of blood pumped per ventricular contraction:     $\text{SV} = \text{EDV} - \text{ESV}$
  • Ejection Fraction (EF) is the percentage of EDV ejected with each beat:     $\text{EF} = \frac{\text{SV}}{\text{EDV}} \times 100\,\%$
  • Typical resting metrics: $\text{EDV} = 130\,\text{mL}$, $\text{ESV} = 50\,\text{mL} \implies \text{SV} = 80\,\text{mL}$, $\text{EF} = 61.5\,\%$.
  • Sympathetically stimulated exercise metrics: $\text{EDV} = 130\,\text{mL}$, $\text{ESV} = 41\,\text{mL} \implies \text{SV} = 89\,\text{mL}$, $\text{EF} = 68.5\,\%$.

• Temporal Changes in Systolic and Diastolic Duration:

  • At rest ($\text{HR} \approx 75\,\text{bpm}$, cycle length $0.80\,\text{s}$):
  • Diastole occupies $0.50\,\text{s}$ ($62\,\%$ of cycle duration).
  • Systole occupies $0.30\,\text{s}$ ($38\,\%$ of cycle duration).
  • During heavy exercise ($\text{HR} \approx 200\,\text{bpm}$, cycle length $0.30\,\text{s}$):
  • Diastole shortens to $0.14\,\text{s}$ ($\sim 47\,\%$ of cycle duration).
  • Systole shortens to $0.16\,\text{s}$ ($\sim 53\,\%$ of cycle duration).
  • Extreme reductions in diastolic filling time at high heart rates eventually constrain ventricular filling and stroke volume.

• Four Physiological Regulators of Stroke Volume During Exercise:
  1. The Skeletal Muscle Pump (Preload / Venous Return):
  • Rhythmic contraction of peripheral skeletal muscle compresses low-pressure capacitance veins, driving blood past one-way venous valves toward the right atrium.
  • Elevates venous return per unit time, raising right atrial and subsequently left ventricular end-diastolic volume (EDV).

2. The Frank-Starling Mechanism (Length-Tension Dynamics):
   • Increased venous return stretches ventricular cardiomyocytes, increasing end-diastolic sarcomere length toward the optimal functional range ($2.0\text{--}2.2\,\mu\text{m}$).
   • This stretch increases troponin C affinity for $\text{Ca}^{2+}$ and optimizes cross-bridge overlap, increasing force production without requiring additional neural stimulation.
   • Worked shift: An increase in EDV from $138\,\text{mL}$ to $205\,\text{mL}$ increases stroke volume from $73\,\text{mL}$ to $102\,\text{mL}$.

3. Sympathetic Inotropy (Myocardial Contractility):
   • Norepinephrine from cardiac sympathetic nerves and circulating epinephrine bind ventricular $\beta_1$-adrenergic receptors.
   • PKA phosphorylation of L-type $\text{Ca}^{2+}$ channels and phospholamban increases both the amplitude of cytosolic $\text{Ca}^{2+}$ transients and the rate of cross-bridge cycling.
   • Produces higher peak ventricular pressures and more complete emptying, shifting the Frank-Starling curve upward and to the left (decreasing ESV from $40\,\text{mL}$ to $30\,\text{mL}$).

4. Decreased Afterload (Arteriolar Vasodilation):
   • Afterload represents the mean aortic resistance opposing ventricular ejection.
   • Functional sympatholysis and local metabolic vasodilators (adenosine, $\text{NO}$, $\text{K}^+$, $\text{H}^+$) relax smooth muscle in the arterioles feeding active skeletal muscle beds, reducing Total Peripheral Resistance (TPR) and facilitating ejection.

• Stroke Volume Plateau Across Graded Exercise:
  • In untrained and moderately active individuals, SV increases linearly with exercise intensity up to $\sim 40\text{--}60\,\%\,\dot{V}\text{O}_2\text{max}$.
  • Beyond $50\,\%\,\dot{V}\text{O}_2\text{max}$, stroke volume plateaus ($\text{SV}_{\text{max}} \approx 110\text{--}120\,\text{mL}\cdot\text{beat}^{-1}$).
  • The plateau occurs because progressive tachycardia shortens diastolic filling time down to $<0.15\,\text{s}$, counterbalancing the effects of elevated venous return and limiting further increases in EDV.

Cardiovascular Integration and Physiological Limits to $\dot{V}\text{O}_2\text{max}$

• Integrated Hemodynamic Delivery Equation:

  • Combining the cardiac output and circulatory Fick equations yields:     $\dot{V}\text{O}_2 = \text{HR} \times \text{SV} \times (a - \bar{v})\text{O}_2$
  • During exercise from rest to $\dot{V}\text{O}_2\text{max}$:
  • Heart rate increases linearly from $\sim 60\text{--}70\,\text{bpm}$ to $\text{HR}_{\text{max}}$.
  • Stroke volume rises from $\sim 70\,\text{mL}\cdot\text{beat}^{-1}$ to plateaus of $\sim 115\text{--}125\,\text{mL}\cdot\text{beat}^{-1}$.
  • Cardiac output ($\dot{Q}$) rises linearly from $\sim 5\,\text{L}\cdot\text{min}^{-1}$ up to $\dot{Q}_{\text{max}}$ ($20\text{--}25\,\text{L}\cdot\text{min}^{-1}$ in healthy young adults).
  • Arteriovenous difference expands from $\sim 50\,\text{mL}\cdot\text{L}^{-1}$ to $\sim 150\text{--}170\,\text{mL}\cdot\text{L}^{-1}$.

• Criteria for True $\dot{V}\text{O}_2\text{max}$:

  • A "true" $\dot{V}\text{O}_2\text{max}$ is verified by a plateau in oxygen uptake, defined as an increase of $<0.15\,\text{L}\cdot\text{min}^{-1}$ ($<150\,\text{mL}\cdot\text{min}^{-1}$) despite an increase in external work rate.
  • Worked incremental step data:
  • $120\,\text{W} \implies \dot{V}\text{O}_2 = 2.22\,\text{L}\cdot\text{min}^{-1}$.
  • $150\,\text{W} \implies \dot{V}\text{O}_2 = 2.50\,\text{L}\cdot\text{min}^{-1}$ (increase of $0.28\,\text{L}\cdot\text{min}^{-1}$).
  • $180\,\text{W} \implies \dot{V}\text{O}_2 = 2.57\,\text{L}\cdot\text{min}^{-1}$ (increase of only $0.07\,\text{L}\cdot\text{min}^{-1}$).
  • Because $0.07\,\text{L}\cdot\text{min}^{-1} < 0.15\,\text{L}\cdot\text{min}^{-1}$, the plateau criterion is fulfilled, identifying $\dot{V}\text{O}_2\text{max}$.

• Physiological Factors Limiting $\dot{V}\text{O}_2\text{max}$:

  • Convective oxygen delivery ($\dot{Q}_{\text{max}} \times a\text{O}_2$) is the primary factor limiting $\dot{V}\text{O}_2\text{max}$ in healthy humans breathing sea-level air.
  • Intramuscular peripheral metabolic capacity (mitochondrial oxidative enzyme activity) exceeds central cardiovascular oxygen delivery.
  • At intensities exceeding $100\,\%\,\dot{V}\text{O}_2\text{max}$, locoregional oxygen delivery to active limbs plateaus or declines as stroke volume plateaus, maximal heart rate is reached, and severe sympathetic vasoconstriction maintains central blood pressure against expanding active vascular beds.